Watch Ticker

Monopar Therapeutics Inc. Common Stock

Go to Monopar Therapeutics Inc. Common Stock Website

$39.28

-2.47 (-5.92%)

Live

Previous Close

$41.75

Day Range

$39.28 - $42.5

Previous Day Range

$39.92 - $42.21

Market Cap

$248.8 million USD

Day Vol.

3794

Previous Day Vol.

28749

Currency

USD

Primary Exchange

Nasdaq

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prev...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Monopar Therapeutics Inc. - Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments

Monopar Therapeutics has in-licensed ALXN-1840, a late-stage drug candidate for Wilson disease, from Alexion, AstraZeneca Rare Disease. The company also has two novel radiopharma clinical trials active and enrolling patients with advanced solid cancers.

Related tickers: MNPR.

Read Full Article

N/A - Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock

Monopar Therapeutics, a clinical-stage biotechnology company, announced the pricing of a $19.2 million public offering of its common stock at $16.25 per share. The proceeds will be used for general corporate purposes, including research and development, clinical trials, and working capital.

Related tickers: MNPR.

Read Full Article

Trending Tickers

Please sign in to view